The CDMO France association

What does CDMO France represent?

The CDMO France association brings together 18 of the main French, European and global pharmaceutical subcontractors having at least one plant located in France.

The main activity of the members of CDMO France is the pharmaceutical manufacturing of health products, medicines and food supplements for third parties. The members also offer development support services, regulatory services and product life cycle services.

Sovereignty

The major industrial network represented by all the French manufacturing plants and their ability to adapt is a key element of France’s health independence.

A complete answer to pharmaceutical subcontracting needs

All the know-how of CDMOs consists to adapt their capabilities, knowledges and technologies to the needs of pharmaceutical companies (Big Pharma, Start-up, Generic companies etc.) in terms of development and production capacity, technologies and regulations.

The Issues

A growing sector of the economy

A growing sector of the economy

Since the beginning of 2010, the French CDMO market has been driven by strong organic growth.

Currently, the members of CDMO France generate 2.5 billion€ of turnover through more than 80 industrial sites located in France. More than 16,000 employees enable the production of 3.3 billion boxes of medicines per year.

• Defending and promoting the attractiveness of the sector

• Defending and promoting the attractiveness of the sector

The primary ambition of the CDMO France association is to give greater visibility of all French CDMOs.

It is important to point out that the pharmaceutical subcontracting sector recruits from a wide variety of professions and throughout the country.

A Framework for exchanges

A Framework for exchanges

The framework of the association encourages exchanges between members in order to reach common actions and positions to defend the interests of French CDMOs.